ストックスクリーナーアプリを入手
3.54
4.84%
-0.18
アフターアワーズ：
3.54
前日終値:
$3.72
開ける：
$3.7495
24時間の取引高:
63,756
Relative Volume:
0.07
時価総額：
$9.14M
収益：
-
当期純損益:
$-19.88M
株価収益率:
-3.8901
EPS:
-0.91
ネットキャッシュフロー:
$-19.93M
1週間 パフォーマンス:
-9.00%
1か月 パフォーマンス:
-9.69%
6か月 パフォーマンス:
-53.74%
1年 パフォーマンス:
-70.76%
1日の値動き範囲:
$3.52
$3.87
1週間の範囲:
$3.46
$3.91
52週間の値動き範囲:
$2.00
$20.60
Purple Biotech Ltd Adr Stock (PPBT) Company Profile
PPBT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PPBT
Purple Biotech Ltd Adr
|
3.54 | 9.14M | 0 | -19.88M | -19.93M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.00 | 108.68B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
681.58 | 74.90B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
640.52 | 38.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
246.27 | 31.76B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
111.93 | 26.83B | 3.30B | -501.07M | 1.03B | -2.1146 |
Purple Biotech Ltd Adr (PPBT) 最新ニュース
PPBT Stock Surges 150% on Superior Efficacy of PDAC Combo Therapy - Yahoo Finance
Why Purple Biotech (PPBT) Stock Is Getting Hammered - Benzinga
Purple Biotech Reports Third Quarter 2024 Financial Results - GlobeNewswire Inc.
Purple Biotech Reports Third Quarter 2024 Financial Results - Yahoo Finance
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.65% - MSN
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.65% - MSN
PPBT stock touches 52-week low at $3.52 amid market challenges - Investing.com India
PPBT stock touches 52-week low at $5.89 amid market challenges - Investing.com India
Purple Biotech price target raised by H.C. Wainwright, maintains Buy rating - Investing.com India
PPBT stock touches 52-week high at $8.02 amid market fluctuations - Investing.com
Ratio Review: Analyzing Purple Biotech Ltd ADR (PPBT)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
What Makes Purple Biotech (PPBT) a New Buy Stock - Yahoo Finance
Purple Biotech stock target cut on trial cohort issue - Investing.com
Purple Biotech granted Nasdaq compliance extension - Investing.com
95 Promising Stocks You Can Currently Buy for Less Than $5 Per Share - GOBankingRates
Purple Biotech stock retains Buy rating from H.C. Wainwright - Investing.com
Why Purple Biotech (PPBT) Shares Are Trading Lower - Benzinga
Purple Biotech shares target cut by Jones Trading on interim Ph2 data - Investing.com
Here's Why Purple Biotech Ltd. Sponsored ADR (PPBT) Could be Great Choice for a Bottom Fisher - Yahoo Finance
Best Penny Stocks Under $1 To Buy Now - AOL
A new, genetically modified purple tomato may hit the grocery market stands - CNN
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts - Benzinga
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study - Markets Insider
Purple Biotech (PPBT) Stock Price, News & Analysis - MarketBeat
Market Data Center - Barron's
The FDA Just Approved Kitov's ConsensiNow What? (NASDAQ:PPBT) - Seeking Alpha
ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN
Purple Biotech Ltd Adr (PPBT) 財務データ
収益
当期純利益
現金流量
EPS
0.65%
4.62%
大文字化:
|
ボリューム (24 時間):